...
首页> 外文期刊>BMC Musculoskeletal Disorders >Adhesive capsulitis of the shoulder, treatment with corticosteroid, corticosteroid with distension or treatment-as-usual; a randomised controlled trial in primary care
【24h】

Adhesive capsulitis of the shoulder, treatment with corticosteroid, corticosteroid with distension or treatment-as-usual; a randomised controlled trial in primary care

机译:肩关节囊膜炎,皮质类固醇激素治疗,皮质类固醇激素扩张或通常治疗;初级保健的随机对照试验

获取原文
           

摘要

Background Optimal management for adhesive shoulder capsulitis (frozen shoulder) is currently unclear. We intended to explore whether treatment by intra-articular injections with corticosteroid and distension is more effective than treating with corticosteroids alone or treatment-as-usual in a primary care setting in Norway. Methods In this prospective randomised intention to treat parallel study, 106 patients were block randomised to three groups; 36 (analysed 35) receiving steroid injection and Lidocaine (IS), 34 receiving steroid and additional saline as distension (ISD) and 36 had treatment-as-usual (TAU). Intervention groups received four injections within 8?weeks, assessed on 1st visit, at the 4th and 8th week. Outcomes were Shoulder Pain and Disability Index (SPADI), Numerical pain rating scale (NPRS) and passive range of motion (PROM). Postal assessment was repeated after 1?year for SPADI. Patients in the IS and ISD groups were “blinded” for intervention received and the assessor was “blinded” to group allocation. Results At baseline there were no differences between groups in outcome measures. There were no statistical significant differences between the intervention groups in SPADI, NPRS and PROM at baseline, at short-term (4-and 8?weeks) or long-term (12?months). There were statistically significant differences ( p ?0.05). Effect size (ES) at 8?weeks was large between both injection groups and TAU (ES 1.2). At 12?months ES was reduced to 0.3 and 0.4 respectively. Transitory side effects as flushing and after-pain were reported by 14?% in intervention groups. Conclusion This intention to treat RCT in primary care indicates that four injections with corticosteroid with or without distension, given with increasing intervals during 8?weeks, were better than treatment-as-usual in treatment of adhesive shoulder capsulitis. However, in the long run no difference was found between any of the groups, indicating that natural healing takes place independent of treatment or not. Trial registration ClinicalTrials.gov, https://clinicaltrials.gov/ identifier: NCT01570985
机译:背景技术目前尚不清楚粘膜性肩囊炎(肩周炎)的最佳治疗方法。我们打算探讨在挪威的初级保健机构中,通过关节内注射皮质类固醇激素和扩张剂的治疗是否比单独使用皮质类固醇激素或常规治疗更有效。方法按照这项前瞻性随机研究意向平行研究,将106例患者随机分为三组。接受类固醇注射和利多卡因(IS)的患者36例(分析35例),接受类固醇和其他生理盐水的扩张(ISD)的患者34例,接受常规治疗(TAU)的患者36例。干预组在第4周和第8周第一次访视时评估的8周内接受了4次注射。结果是肩痛和残疾指数(SPADI),数字疼痛等级量表(NPRS)和被动运动范围(PROM)。 1年后对SPADI重复邮寄评估。 IS和ISD组的患者被“盲目”接受干预,评估者被“盲目”进行组分配。结果基线时,两组之间的结局指标没有差异。在基线,短期(4周和8周)或长期(12周)时,SPADI,NPRS和PROM干预组之间无统计学差异。在统计学上有显着差异(P <0.05)。两个注射组和TAU之间在8周时的效应量(ES)都很大(ES 1.2)。在12个月时,ES分别降至0.3和0.4。据报道,干预组的短暂性副作用如潮红和疼痛后发生率为14%。结论在初级保健中治疗RCT的意图表明,在8周内,以4次间隔增加的间隔注射四次皮质类固醇药物,不论是否扩张,均优于常规治疗黏膜性肩周炎的方法。但是,从长远来看,任何一组之间都没有发现差异,这表明自然治愈的发生与治疗无关。试用注册ClinicalTrials.gov,https://clinicaltrials.gov/标识符:NCT01570985

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号